In Vitro Safety & Neurotoxicology Intern
Genentech
In Vitro Safety & Neurotoxicology Intern
Genentech
Biotech firm creating medicines via R&D
2027 Summer Intern - In Vitro Safety & Neurotoxicology
Department Summary
Development Sciences (DevSci) spans the entire drug discovery and development cycle — from early stage research to drug commercialization. Part of the drug development pipeline in DevSci includes the preclinical safety evaluation of candidate therapeutic molecules by toxicologists and pathologists in the Translational Safety (TS) department in order to enable further evaluation in humans. We develop transformative therapeutics for patients by delivering rigorous translational strategies and model-informed predictive insights for all therapeutic modalities through the entire drug development lifecycle via innovative experimental and computational approaches.
The Complex in Vitro Systems lab (CiS) within TS develops and characterizes models that have the potential to reduce or replace the use of animals in the assessment of efficacy, biodistribution, and toxicity. CiS works closely with scientists across Roche to develop, deploy, and democratize complex in vitro models. Using a variety of assessments in collaboration with pathologists, image analysis scientists, and computational scientists, CiS aims to provide high quality predictive toxicology data that helps to derisk and/or understand the clinical relevance of potential adverse drug reactions.
This internship position is located in South San Francisco, on-site.
The Opportunity
The Complex in vitro Systems group is seeking a motivated intern to support the onboarding and qualification of a human in vitro multielectrode array (MEA) assay designed for early prediction of compound-induced seizure liability. To overcome the temporal resolution limitations of conventional optical assays, the intern will optimize 2D human iPSC-derived excitatory/inhibitory neuron and astrocyte co-cultures on high-density MEA platforms to capture rapid, circuit-level action potentials and network burst dynamics. Key responsibilities include evaluating plating densities and cell formulations, executing acute and long-term compound dosing studies, and analyzing multi-parametric electrophysiological readouts to distinguish specific seizurogenic phenotypes from general neurotoxicity. By screening a benchmark panel of historical internal molecules and literature controls with known in vivo outcomes, the intern will help establish assay sensitivity, specificity, and predictive cutoffs, establishing a crucial safety de-risking platform for early discovery pipelines.
Responsibilities include:
Program Highlights
Who You Are
Required Education
Required Majors: Neuroscience, Bioengineering, Biomedical Sciences, Pharmacology, or a related scientific discipline.
Required Skills
Preferred Knowledge, Skills, and Qualifications
Relocation benefits are not available for this job posting.
The expected salary range for this position based on the primary location of California is $47.00 per hour. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. This position also qualifies for paid holiday time off benefits.
Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws.
If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants.
Genentech develops medicines and therapies to address unmet medical needs through extensive biotechnology research and development. Its products include biologic and small-molecule treatments prescribed by healthcare providers and sold through partnerships with suppliers and health systems. It differentiates itself with a large R&D footprint, a vast patent portfolio, and FDA Breakthrough Therapy Designations that accelerate promising therapies. Its goal is to advance medical science and deliver high-quality, effective therapies that improve patient health while supporting the broader medical community.
Explore more opportunities at Genentech